Related Experiment Video

Updated: Aug 14, 2026

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
11:21

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

Potential applications of apoptosis in modifying the biological behavior of therapeutically refractory cancers

K M Anderson1, J E Harris, P Bonomi

  • 1Department of Medicine, Rush Medical College, Chicago, IL 60612.

Medical Hypotheses
|October 1, 1994
PubMed

Insights

Investigating programmed cell death (apoptosis), the BCL2 gene, and reactive oxygen species reveals their roles in cancer resistance. Understanding these interactions may offer new therapeutic strategies for difficult-to-treat cancers.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Biochemistry

Background:

  • Apoptosis, or programmed cell death, is a critical cellular process.
  • The BCL2 gene plays a key role in regulating apoptosis.
  • Reactive oxygen species (ROS) are implicated in cellular signaling and stress responses.

Purpose of the Study:

  • To discuss the intricate relationships between apoptosis, the anti-apoptotic gene BCL2, and reactive oxygen species.
  • To explore the involvement of these factors in cellular senescence and apoptosis.
  • To identify potential novel therapeutic strategies for resistant cancers.

Main Methods:

  • Literature review and synthesis of recent findings.
  • Analysis of molecular mechanisms.
  • Conceptual discussion of biological interactions.

Main Results:

  • Recent data highlight the complex interplay between BCL2, ROS, senescence, and apoptosis.
  • These interactions are crucial in the context of cancer biology.
  • Understanding these relationships can inform therapeutic development.

Conclusions:

  • The interplay between BCL2, ROS, and apoptosis offers potential avenues for targeting therapeutically resistant cancers.
  • Further research into these molecular mechanisms may yield innovative treatment approaches.
  • This discussion provides a foundation for future experimental studies.

More Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...